CIZ — Cizzle Biotechnology Holdings Income Statement
0.000.00%
Last trade - 00:00- £5.95m
- £5.13m
Annual income statement for Cizzle Biotechnology Holdings, fiscal year end - December 31st, GBP millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Cost of Revenue | |||||
| Gross Profit | 0 | 0 | 0 | 0 | — |
| Selling / General / Administrative Expenses | |||||
| Unusual Expense / Income | |||||
| Total Operating Expenses | 0.832 | 0.306 | 3.96 | 0.963 | 1.76 |
| Operating Profit | -0.832 | -0.306 | -3.96 | -0.963 | -1.76 |
| Net Income Before Taxes | -0.832 | -0.306 | -3.96 | -0.963 | -1.76 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -0.832 | -0.306 | -3.92 | -0.912 | -1.72 |
| Net Income Before Extraordinary Items | |||||
| Net Income | -0.832 | -0.306 | -3.92 | -0.912 | -1.72 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -0.832 | -0.306 | -3.92 | -0.912 | -1.72 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -0 | -0.001 | -0.014 | -0.003 | -0.005 |